Skip to content. | Skip to navigation

Personal tools
Sections
You are here: Home topics Health Health Guides
Document Actions

Health Guides

Up one level
Guides on the EU Health policy.
New EU measures on vaccine-preventable cancers - guide by EUbusiness — last modified 01 February 2024, 11:52 CET
The European Commission on 31 January put forward a Recommendation to support EU Member States in their efforts to prevent cancer through vaccination. Notably, it focuses on boosting the uptake of two key vaccinations that can prevent viral infections that may lead to cancer: against Human papillomaviruses (HPV) and Hepatitis B virus (HBV), as well as improving the monitoring of coverage rates.
In vitro diagnostics and the European Database on Medical Devices (EUDAMED) - guide by EUbusiness — last modified 23 January 2024, 23:48 CET
The European Commission proposed on 23 January more time for companies to apply the In Vitro Diagnostic Medical Devices Regulation (IVDR), under certain conditions, as well as measures to enhance transparency in the medical device sector including speeding up the launch of some elements of the European Database on Medical Devices - EUDAMED.
Medicine Shortages in the EU - guide by EUbusiness — last modified 24 October 2023, 21:27 CET
The European Commission adopted on 24 October a set of actions to better prevent and mitigate critical medicine shortages in the EU, this winter, next winter and beyond.
EU Commission agreement with BioNTech-Pfizer on the delivery of vaccines - guide by EUbusiness — last modified 26 May 2023, 23:27 CET
The EU Commission, acting with EU states and vaccine developers BioNTech-Pfizer, reached an agreement on 26 May to better address Member States' assessment of evolving needs for COVID-19 vaccines.
Revision of EU pharmaceutical legislation - guide by EUbusiness — last modified 26 April 2023, 18:25 CET
The European Commission proposed on 26 April to revise the EU's pharmaceutical legislation - the largest reform in over 20 years - to make it more agile, flexible, and adapted to the needs of citizens and businesses across the EU. The revision will make medicines more available, accessible and affordable.
Council Recommendation on stepping up EU actions to combat AMR in a One Health approach - guide by EUbusiness — last modified 26 April 2023, 18:28 CET
The European Commission proposed on 26 April 2023 a major revision of the EU's pharmaceutical legislation. The package also includes a proposal for a Council Recommendation containing complementary measures to combat AMR in the fields of human health, animal health and the environment, through the so-called One Health approach.
Commission proposes extension of transitional periods for application of the Medical Devices Regulation by EUbusiness — last modified 10 January 2023, 18:30 CET
The European Commission adopted on 6 January a proposal to give more time to certify medical devices to mitigate the risk of shortages.
EU Global Health Strategy - guide by EUbusiness — last modified 30 November 2022, 22:08 CET
The European Commission adopted on 30 November a new EU Global Health Strategy to improve global health security and deliver better health for all in a changing world.
New EU approach to cancer screening - guide by EUbusiness — last modified 21 September 2022, 23:45 CET
As part of the EU Cancer Screening Scheme to be put forward under Europe's Beating Cancer Plan, the European Commission presented on 21 September a new approach to support Member States increasing the uptake of cancer screening.
European Care Strategy - guide by EUbusiness — last modified 07 September 2022, 22:46 CET
The European Commission presented on 7 September the European Care Strategy to ensure quality, affordable and accessible care services across the European Union and improve the situation for both care receivers and the people caring for them, professionally or informally.
Stronger rules for placing medical tests on the market - guide by EUbusiness — last modified 25 May 2022, 21:27 CET
As of 26 May, new rules on in vitro diagnostic medical devices (IVDR) such as HIV tests, pregnancy tests or COVID-19 tests, are applicable.
Proposal to ensure continued supply of medicines to Northern Ireland, as well as Cyprus, Ireland and Malta by EUbusiness — last modified 12 April 2022, 23:35 CET
The EU Council adopted on 12 April proposals to ensure the continued long-term supply of medicines from Great Britain to Northern Ireland and to address outstanding supply concerns in Cyprus, Ireland and Malta.
Regulation on Health Technology Assessment by EUbusiness — last modified 13 December 2021, 22:57 CET
The Regulation on Health Technology Assessment (HTA), a deliverable of the EU Pharmaceutical Strategy, was adopted on 13 December.
European Health Emergency preparedness and Response Authority - HERA by EUbusiness — last modified 20 September 2021, 20:58 CET
The European Commission is launching the European Health Emergency preparedness and Response Authority (HERA) to prevent, detect, and rapidly respond to health emergencies. HERA will anticipate threats and potential health crises, through intelligence gathering and building the necessary response capacities.
Application of Regulation on Medical Devices - EU rules for safety of medical devices by EUbusiness — last modified 26 May 2021, 18:03 CET
As of 26 May, new EU rules on medical devices (MDR) enter into application, establishing a modern and more robust regulatory framework to protect public health and patient safety.
Funding strategy for NextGenerationEU by EUbusiness — last modified 15 April 2021, 00:19 CET
The European took steps on 14 April to ensure that borrowing under the temporary recovery instrument NextGenerationEU will be financed on the most advantageous terms for EU Member States and their citizens.
EU4Health Programme 2021-2027 by EUbusiness — last modified 26 March 2021, 23:09 CET
The EU4Health programme came into force on 26 March, making EUR 5.1 billion available to strengthen the resilience of Europe's health systems and promote innovation in the health sector.
EU Digital COVID Certificate by EUbusiness — last modified 01 July 2021, 17:54 CET
The EU Digital COVID Certificate (formerly called Digital Green Certificate) will facilitate safe free movement during the COVID-19 pandemic within the EU. It will serve as proof that a person was vaccinated against COVID-19, received a negative test result or recovered from COVID-19. The certificate can be used across all EU Member States as well as in Iceland, Liechtenstein and Norway. Contacts are also ongoing to enable its use with Switzerland. The Commission is working to make sure that the certificates can be compatible with systems in other countries outside the EU.
HERA Incubator - Anticipating COVID-19 variants by EUbusiness — last modified 17 February 2021, 21:22 CET
The European Commission proposed on 17 February the "HERA Incubator", the Health Emergency Preparedness and Response Authority (HERA) Incubator to prepare Europe for the increased threat of coronavirus variants.
Recovery and Resilience Facility - background guide by EUbusiness — last modified 10 February 2021, 14:18 CET
The RRF is the key instrument at the heart of NextGenerationEU, the EU's plan for emerging stronger from the COVID-19 pandemic. It will play a crucial role in helping Europe recover from the economic and social impact of the pandemic and will help to make the EU's economies and societies more resilient and secure the green and digital transitions.